Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up.
Classical variant
Follicular variant
Papillary thyroid cancer
Tumor capsule
Tumor dimension
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
07
01
2020
accepted:
12
02
2020
pubmed:
4
3
2020
medline:
22
6
2021
entrez:
4
3
2020
Statut:
ppublish
Résumé
To compare the epidemiological, clinical, and pathological features of follicular (FVPTC) and classical (CVPTC) variants of papillary thyroid cancer and to correlate their outcomes according to different features. Retrospective analysis of FVPTC and CVPTC patients selected at the moment of surgical treatment from 1999 to 2004, with a median follow-up of 15 years. Several significant differences were found between FVPTC and CVPTC such as the mean age at diagnosis, the presence of tumor capsule, the presence of thyroid capsule invasion, the presence of perithyroid soft tissue invasion, the lymph node metastases, the multifocality and bilaterality. At the end of follow-up only 9% (77/879) patients were not cured. However, a statistically significant lower percentage of persistent disease was found in the FVPTC than in the CVPTC group (3% vs. 14.5%, respectively, p < 0.0001). In multivariate analysis, the absence of the tumor capsule (OR = 6.75) or its invasion (OR = 7.89), the tumor size ≥4 cm (OR = 4.29), the variant CVPTC (OR = 3.35), and the presence of lymph node metastases (OR = 3.16) were all independent risk factors for the persistence of the disease. Despite an overall excellent prognosis of both variants, a higher percentage of CVPTC than FVPTC patients had a persistent disease. The absence of tumor capsule or its invasion, the tumor size ≥4 cm and the presence of lymph node metastases are other prognostic factors for the persistence of the disease. In contrast, the presence of an intact tumor capsule is the only good prognostic factor for their outcome.
Identifiants
pubmed: 32124258
doi: 10.1007/s12020-020-02229-0
pii: 10.1007/s12020-020-02229-0
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
607-616Références
G. Jossart, O. Clark, Well-differentiated thyroid cancer. Curr. Probl. Surg. 31, 933–1012 (1994)
doi: 10.1016/0011-3840(94)90063-9
A.K.Y. Lam, C.Y. Lo, K.S.L. Lam, Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr. Pathol. 16, 323–330 (2005)
doi: 10.1385/EP:16:4:323
M.L. Carcangiu, G. Zampi, A. Pupi, A. Castagnoli, J. Rosai, Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55, 805–828 (1985)
doi: 10.1002/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO;2-Z
S.O. Sebastian, J.M. Gonzalez, P.P. Paricio, J.S. Perez, D.P. Flores, A.P. Madrona, P.R. Romero, F.J. Tebar, Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch. Surg. 135, 272–277 (2000)
doi: 10.1001/archsurg.135.3.272
X.-M. Yu, D.F. Schneider, G. Leverson, H. Chen, R.S. Sippel, Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid 23, 1263–1268 (2013)
doi: 10.1089/thy.2012.0453
E.T. Tielens, S.I. Sherman, R.H. Hruban, P.W. Ladenson, Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73, 424–431 (1994)
doi: 10.1002/1097-0142(19940115)73:2<424::AID-CNCR2820730230>3.0.CO;2-I
V.A. Livolsi, Papillary thyroid carcinoma: an update. Mod Pathol 24, S1–S9 (2011)
G. Crile, J.B. Hazard, Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann. Surg. 138, 33–38 (1953)
doi: 10.1097/00000658-195307000-00005
M. Dailey, M. Soley, S. Lindsay, Carcinoma of the thyroid gland; a clinical and pathologic study. Am. J. Med 9, 194–199 (1950)
doi: 10.1016/0002-9343(50)90022-2
L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167 (2006)
doi: 10.1001/jama.295.18.2164
A.Y. Chen, A. Jemal, E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer 115, 3801–3807 (2009)
doi: 10.1002/cncr.24416
H.Y. Chang, J. Der Lin, S.C. Chou, T.C. Chao, C. Hsueh, Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas. Jpn J. Clin. Oncol. 36, 688–693 (2006)
doi: 10.1093/jjco/hyl093
Z.W. Baloch, V.A. Livolsi, Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod. Pathol. 13, 861–865 (2000)
doi: 10.1038/modpathol.3880153
P. Hagag, N. Hod, E. Kummer, M. Cohenpour, T. Horne, M. Weiss, Follicular variant of papillary thyroid carcinoma: clinical-pathological characterization and long-term follow-up. Cancer J. 12, 275–282 (2006)
doi: 10.1097/00130404-200607000-00005
B.H.H. Lang, C.Y. Lo, W.F. Chan, A.K.Y. Lam, K.Y. Wan, Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J. Surg. 30, 752–758 (2006)
doi: 10.1007/s00268-005-0356-7
J. Zidan, D. Karen, M. Stein, E. Rosenblatt, W. Basher, A. Kuten, Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 97, 1181–1185 (2003)
doi: 10.1002/cncr.11175
C. Passler, G. Prager, C. Scheuba, B.E. Niederle, K. Kaserer, G. Zettinig, B. Niederle, Follicular variant of papillary thyroid carcinoma: a long-term follow-up. Arch. Surg. 138, 1362–1366 (2003)
doi: 10.1001/archsurg.138.12.1362
A.R. Burningham, J. Krishnan, B.J. Davidson, M.D. Ringel, K.D. Burman, Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy. Otolaryngol. Head. Neck Surg. 132, 840–844 (2005)
doi: 10.1016/j.otohns.2005.02.002
X. Shi, R. Liu, F. Basolo, R. Giannini, X. Shen, D. Teng, H. Guan, Z. Shan, W. Teng, T.J. Musholt, K. Al-Kuraya, L. Fugazzola, C. Colombo, E. Kebebew, B. Jarzab, A. Czarniecka, B. Bendlova, V. Sykorova, M. Sobrinho-Simães, P. Soares, Y.K. Shong, T.Y. Kim, S. Cheng, S.L. Asa, D. Viola, R. Elisei, L. Yip, C. Mian, F. Vianello, Y. Wang, S. Zhao, G. Oler, J.M. Cerutti, E. Puxeddu, S. Qu, Q. Wei, H. Xu, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, A.K. Lam, G. Riesco-Eizaguirre, P. Santisteban, H. Yu, G. Tallini, E.H. Holt, V. Vasko, M. Xing, Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J. Clin. Endocrinol. Metab. 101, 264–274 (2016)
doi: 10.1210/jc.2015-2917
Y.E. Nikiforov, R.R. Seethala, G. Tallini, Z.W. Baloch, F. Basolo, L.D.R. Thompson, J.A. Barletta, B.M. Wenig, GhuzlanA. Al, K. Kakudo, T.J. Giordano, V.A. Alves, E. Khanafshar, S.L. Asa, A.K. El-Naggar, W.E. Gooding, S.P. Hodak, R.V. Lloyd, G. Maytal, O. Mete, M.N. Nikiforova, V. Nosé, M. Papotti, D.N. Poller, P.M. Sadow, A.S. Tischler, T.R. Michael, K.B. Wall, V.A. LiVolsi, G.W. Randolph, R.A. Ghossein, Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2, 1023–1029 (2016)
doi: 10.1001/jamaoncol.2016.0386
Y.E. Nikiforov, Z.W. Baloch, S.P. Hodak, T.J. Giordano, R.V. Lloyd, R.R. Seethala, B.M. Wenig, Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features. JAMA Oncol 4, 1125–1126 (2018)
doi: 10.1001/jamaoncol.2018.1446
S.B. Edge, A.G. Fritz, D.A. Byrd, F.L. Greene, A. Trotty, C.C. Compton. AJCC cancer staging manuel, 7th edn. (2010). https://doi.org/10.1007/978-1-4757-3656-4
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)
doi: 10.1089/thy.2015.0020
F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W.A. Smit, W. Wiersinga, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)
doi: 10.1530/eje.1.02158
R.A. DeLellis, R.V. Lloyd, P.U. Heitz. EC, editors. World Health Organization International Classification of Tumors. Pathology and Genetics of Tumors of Endocrine Organs. Lyon, France: IARC Press (2004)
F. Tunca, I.C. Sormaz, Y. Iscan, Y.G. Senyurek, T. Terzioglu, Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma. J. Endocrinol. Investig 38, 1327–1334 (2015)
doi: 10.1007/s40618-015-0376-6
R. Elisei, E. Molinaro, L. Agate, V. Bottici, L. Masserini, C. Ceccarelli, F. Lippi, L. Grasso, F. Basolo, G. Bevilacqua, P. Miccoli, G. Di Coscio, P. Vitti, F. Pacini, A. Pinchera, Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J. Clin. Endocrinol. Metab. 95, 1516–1527 (2010)
doi: 10.1210/jc.2009-1536
R. Elisei, D. Viola, L. Torregrossa, R. Giannini, C. Romei, C. Ugolini, E. Molinaro, L. Agate, A. Biagini, C. Lupi, L. Valerio, G. Materazzi, P. Miccoli, P. Piaggi, A. Pinchera, P. Vitti, F. Basolo, The BRAFV600E mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study. J. Clin. Endocrinol. Metab. 97, 4390–4398 (2012)
doi: 10.1210/jc.2012-1775
F. Wang, X. Yu, X. Shen, G. Zhu, Y. Huang, R. Liu, D. Viola, R. Elisei, E. Puxeddu, L. Fugazzola, C. Colombo, B. Jarzab, A. Czarniecka, A.K. Lam, C. Mian, F. Vianello, L. Yip, G. Riesco-Eizaguirre, P. Santisteban, C.J. O’Neill, M.S. Sywak, R. Clifton-Bligh, B. Bendlova, V. Sýkorová, Y. Wang, S. Liu, J. Zhao, S. Zhao, M. Xing, The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer. J. Clin. Endocrinol. Metab. 102, 3241–3250 (2017)
doi: 10.1210/jc.2017-00277
G. Sapuppo, M. Tavarelli, A. Belfiore, R. Vigneri, G. Pellegriti, Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes. J. Clin. Endocrinol. Metab. 104, 258–265 (2018)
doi: 10.1210/jc.2018-01383